Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Revista Colombiana de Reumatología
Print version ISSN 0121-8123
Abstract
GONZALEZ, Luis Alonso; SANTAMARIA-ALZA, Yeison and ALARCON, Graciela S.. Organ damage in systemic lupus erythematosus. Rev.Colomb.Reumatol. [online]. 2021, vol.28, suppl.1, pp.66-81. Epub Feb 20, 2022. ISSN 0121-8123. https://doi.org/10.1016/j.rcreu.2021.01.008.
Damage reflects the irreversible changes that occur in systemic lupus erythematosus (SLE) patients as a consequence of the disease, its treatment or comorbidities. The pattern of damage increases in a steady linear fashion over time. At least half of all patients with SLE will have some form of organ damage 10 years after their diagnosis. Factors associated with the occurrence of damage include older age, disease duration, male gender, non-Caucasian ethnicity, disease activity, corticosteroid use, poverty, hypertension and abnormal illness behaviors. In contrast, antimalarials are protective against damage. Since damage predicts further damage and mortality, prevention of damage accrual should be a major therapeutic goal in SLE. Novel therapies for SLE that achieve better control of the disease and with corticosteroid-sparing properties, may lead to improved outcomes in patients as they will reduce damage accrual and improve survival.
Keywords : Systemic lupus erythematosus; Damage; Disease activity; Corticosteroids; Mortality.